Earningsreport

Q2/2025 3/31/2025 EPS -0.110 ZacksConsensus -1.080 ActVsEst 0.970 - Beat

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com